Kerala HC Permits HRT Continuation for Trans Petitioners Challenging 2026 Amendment
In a significant interim ruling on Friday, April 10, the Kerala High Court directed the continuance of hormone replacement therapy (HRT) for two transgender petitioners challenging the constitutionality of the Transgender Persons (Protection of Rights) Amendment Act, 2026. Justice Bechu Kurian Thomas emphasized the potential for "absurd results" from abruptly halting ongoing treatments, granting relief conditioned on the therapy having already commenced. While refusing to stay the controversial amendment, the court underscored the primacy of individual medical rights under Article 21, navigating the tension between legislative reforms and personal health imperatives.
This order emerges amid broader petitions seeking to strike down key provisions of the 2026 amendment, which narrows protections for transgender individuals. The decision highlights judicial caution in constitutional challenges while prioritizing urgent humanitarian concerns.
Background: Evolution of Transgender Rights Legislation in India
India's transgender rights framework has evolved rapidly since the landmark National Legal Services Authority v. Union of India (NALSA, 2014), where the Supreme Court recognized transgender persons as a "third gender" and affirmed the right to self-identification of gender identity under Articles 14, 15, 19, and 21. This paved the way for the Transgender Persons (Protection of Rights) Act, 2019, which defined a "transgender person" under Section 2(k) inclusively: "a person whose gender does not match with the gender assigned to that person at birth and includes trans-men and trans-women (whether or not they have undergone sex reassignment surgery or hormone therapy or laser therapy etc.) ."
The 2026 Amendment, however, introduces gatekeeping by excluding
"transexual persons and non-binary individuals who identify on the basis of self-perceived gender identity without medical intervention."
Critics argue this shifts from self-perception to mandatory medical validation, potentially reviving pre-NALSA barriers and violating fundamental rights to dignity and non-discrimination.
Government rationale, as hinted in hearings, appears aimed at curbing perceived excesses of "Western concepts," such as unsubstantiated self-identifications (e.g., the court's oral reference to children identifying as cats or animals). The amendment seeks to protect bona fide transgender persons undergoing verifiable medical transitions while excluding casual self-declarations, aligning with international debates (e.g., U.S. controversies over gender fluidity).
Yet, unintended consequences have surfaced: hospitals reportedly halting non-surgical HRT due to a "chilling effect," fearing non-compliance with the redefined protections. One petitioner has been on HRT since 2019, facing sudden denial of care.
The Petitions: Seeking Constitutional Safeguards and Policy Reforms
Filed by Advocate Padma Lakshmi, the two petitions assail the amendment—particularly the revised Section 2(k)—as ultra vires Articles 13(2), 14 (equality), 15 (non-discrimination), 19 (freedoms), and 21 (life and liberty). Petitioners assert that self-identification of gender is a fundamental right, unencumbered by medical or bureaucratic hurdles.
Reliefs sought include: - Declaration of unconstitutionality for imposing invasive criteria. - Directives to frame inclusive policies on education, employment, healthcare, housing, and social security for all transgender identities (transmen, transwomen, non-binary). - Recognition of HRT and non-surgical interventions without stigma.
The pleas highlight immediate harms: post-amendment, doctors have "abruptly" stopped treatments, triggering medical crises. Senior Advocate Arundhati Katju, representing the petitioners, stressed urgency, noting one client's long-term therapy dependency.
Court Proceedings: Tense Exchanges on Urgency and Evidence
Justice Thomas issued notice to the Union of India, represented by Additional Solicitor General P. Sreekumar. Katju urged interim protection, arguing legal merits could be resolved later but treatment stoppage posed irreversible risks.
"The petitioner is a person who is currently undergoing hormone replacement therapy and now it has abruptly stopped,"
she submitted, citing a 2019 commencement.
The court probed evidence:
"What is there to show that you were undergoing therapy?"
Documents were tendered across the bar. For the second petitioner, pleadings noted a medical condition precluding surgery, with fears of halted care due to short notice.
ASG Sreekumar countered no "medical urgency," clarifying the amendment targets "self-declaration" only, not hormone treatments:
"Amendment only excludes self-declaration. Self-declaring is a different category... amendment also includes hormone treatment."
He invoked international issues and the presumption of constitutionality, rare for stays at admission stage.
Justice Thomas orally interjected:
"Let the petitioners' medical treatment continue,"
acknowledging statutory gaps:
"This should have been taken care of by the statute."
He noted the 2019 start for one petitioner was
"not protected under the statute,"
yet warranted protection.
Interim Order: Qualified Relief in the Interest of Justice
Balancing equities, the court passed a nuanced direction:
"This Court is of the view that considering the interest of Justice, the hormone replacement therapy, if already commenced, in respect to the petitioners, shall be continued till its conclusion without any interference from any statutory authority."
Earlier reasoning crystalized the peril:
"Have regard to the entire circumstances, this Court is of the view that abrupt replacement of the hormone replacement therapy allegedly undergone by the petitioner would lead to absurd results."
The order is "qualified by the condition" of prior commencement, ensuring no blanket endorsement. No stay on the Act, respecting legislative presumption.
Legal Analysis: Article 21, Presumption of Constitutionality, and Interim Standards
This ruling exemplifies judicial balancing in socio-legal reforms. Article 21's expansive right to health—encompassing dignified medical access ( Common Cause v. Union of India , 2018; Justice K.S. Puttaswamy , 2017)—trumps abrupt disruptions, even if statutorily unprotected. Abrupt HRT cessation risks osteoporosis, depression, and cardiovascular issues, rendering it prima facie arbitrary under Article 14.
Yet, courts hesitate on statutory stays pre-merits ( Union of India v. G. Ganayutham , 1997), favoring "individualized relief" where balance of convenience tilts (irreparable injury vs. public interest). Here, minimal prejudice to the state justified the carve-out, echoing NALSA 's progressive spirit without upending the amendment.
The "chilling effect" doctrine ( Shreya Singhal v. Union of India , 2015) applies: law-induced doctor hesitancy chills Art 21/19(1)(g) rights. Critically, the order exposes legislative drafting flaws—failing "savings clauses" for ongoing treatments.
Implications for Legal Practice and Transgender Rights Landscape
For practitioners, this signals strategy: In first-admission challenges, pivot to personal interim reliefs with medical evidence, bypassing high stay thresholds. Trans rights litigators can leverage Art 21 for urgent applications, potentially cascading to other HCs.
Healthcare providers face clarity: Ongoing HRT permissible, but new self-ID cases riskier. This may spur guidelines from the National Medical Commission, mitigating "fear in the wards."
Broader impacts: Reinforces trans persons' vulnerability, urging Parliament to revisit exclusions. It critiques over-correction against self-ID abuses, risking regression from NALSA . Internationally, parallels UK's Cass Review (2024) emphasizing evidence-based care, but India's constitutional overlay demands inclusivity.
Policy-wise, the petitions' call for holistic frameworks (healthcare access sans barriers) merits attention, aligning with SDG 3/10.
Looking Ahead: Full Hearing and Judicial Trends
Posted for June, the case may test amendment vires, potentially reaching the Supreme Court. Justice Thomas's approach—protective yet restrained—foreshadows cautious scrutiny, prioritizing evidence over ideology. As trans rights intersect politics, such rulings safeguard margins while upholding rule of law.
This Kerala HC intervention not only averts immediate crises but recalibrates the self-ID vs. verification debate, ensuring legislation evolves without collateral harm.